Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02915432 | The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC | unknown | Phase 1 / Phase 2 | 401 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Dec 13, 2021 | clinicaltrials |
| NCT04443478 | Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer | unknown | — | 1,036 | Peking UniversityOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT04751591 | Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor | unknown | N/A | 260 | Shanghai Zhongshan HospitalOTHER | 0 | Nov 30, 2021 | clinicaltrials |
| NCT05113459 | Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） | unknown | Phase 2 | 40 | Guoxin LiOTHER | 0 | Nov 9, 2021 | clinicaltrials |
| NCT05100446 | Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection | unknown | Early Phase 1 | 100 | Unidade Local de Saúde do Alto Ave, EPEOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT04740346 | Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP) | unknown | N/A | 886 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05095636 | Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 102 | Fudan UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05009966 | Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor | unknown | Phase 1 | 272 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05071755 | Gastrectomy Outcomes in Elderly Patients(GOE) | unknown | — | 350 | Marmara UniversityOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT05070598 | Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer | unknown | Phase 2 | 35 | Shengjing HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04006821 | PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma | unknown | Phase 2 | 30 | China Medical University, ChinaOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT05051423 | "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)(THERRES) | unknown | — | 40 | University of Medicine and Pharmacy CraiovaOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT04607057 | Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient(SUPPORT) | unknown | Phase 4 | 224 | Seoul National University HospitalOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT04434963 | Safety and Feasibility of Reversible Induction Strategy | unknown | — | 20 | RenJi HospitalOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers(ARMANI) | unknown | Phase 3 | 280 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT05039333 | Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation | unknown | — | 36 | Hutom CorpINDUSTRY | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04622098 | Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt | unknown | — | 2,000 | Kafrelsheikh UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT04982939 | Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer | unknown | Phase 2 | 210 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT05029453 | Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy | unknown | Phase 4 | 60 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT04526470 | Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer | unknown | Phase 1 / Phase 2 | 55 | Seoul National University Bundang HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05002686 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | unknown | Phase 2 / Phase 3 | 60 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05007912 | Prospective Observational Study Comparing the Use of Circular (Orvil) and Linear Stapler for Intracorporeal Esophagojejunostomy | unknown | — | 100 | Seoul National University Bundang HospitalOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04890392 | Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC | unknown | Phase 2 | 20 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT03079596 | ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy | unknown | N/A | 100 | Seoul National University Bundang HospitalOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT05000554 | The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer | unknown | Phase 2 | 30 | The First Hospital of Jilin UniversityOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT05001321 | Multi-center and Multi-modal Deep Learning Study of Gastric Cancer | unknown | — | 3,300 | First Hospital of China Medical UniversityOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04993378 | Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy | unknown | — | 40 | Shen LinOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT04989153 | Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer | unknown | — | 5,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04980950 | "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | unknown | N/A | 80 | Medical University of GdanskOTHER | 0 | Jul 30, 2021 | clinicaltrials |
| NCT04973475 | Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer | unknown | Phase 2 | 180 | Fujian Medical UniversityOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | unknown | Phase 3 | 388 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04957407 | The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning | unknown | — | 5,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04943653 | Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis(IPXELOX) | unknown | Phase 1 / Phase 2 | 61 | Seoul St. Mary's HospitalOTHER | 1 | Jul 6, 2021 | clinicaltrials |
| NCT04947995 | Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer(MONITOR- GAC) | unknown | — | 450 | GeneCast Biotechnology Co., Ltd.INDUSTRY | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04948125 | Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma | unknown | Phase 2 | 20 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04934618 | A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 85 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT04915807 | Real-world Data (RWD) of Ramucirumab Plus Paclitaxel | unknown | — | 222 | Hallym University Medical CenterOTHER | 1 | Jun 7, 2021 | clinicaltrials |
| NCT04913662 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis | unknown | Phase 1 | 18 | Seoul National University Bundang HospitalOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04913896 | CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy | unknown | — | 200 | The First Hospital of Jilin UniversityOTHER | 0 | Jun 4, 2021 | clinicaltrials |
| NCT03961867 | Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma | unknown | Phase 3 | 440 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04907864 | Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)(MIRACLE) | unknown | Phase 2 | 112 | Kil Yeon LeeOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04888663 | Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study) | unknown | Phase 1 / Phase 2 | 50 | Yonsei UniversityOTHER | 1 | May 21, 2021 | clinicaltrials |
| NCT04781686 | Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer | unknown | Phase 2 | 35 | Zhou FuxiangOTHER | 1 | May 17, 2021 | clinicaltrials |
| NCT04889768 | HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis | unknown | N/A | 46 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2021 | clinicaltrials |
| NCT04886193 | FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis | unknown | N/A | 20 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT04864821 | Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor | unknown | Early Phase 1 | 24 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 0 | May 6, 2021 | clinicaltrials |
| NCT03208621 | Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer(PLASTIC) | unknown | — | 394 | UMC UtrechtOTHER | 1 | May 5, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Dec 13, 2021source: clinicaltrials